AK HB216 | 2023-2024 | 33rd Legislature
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 16 2024 - 25% progression, died in committee
Action: 2024-01-16 - REFERRED TO HEALTH & SOCIAL SERVICES
Pending: House Health & Social Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 16 2024 - 25% progression, died in committee
Action: 2024-01-16 - REFERRED TO HEALTH & SOCIAL SERVICES
Pending: House Health & Social Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
An Act relating to required disclosures for gene therapy products.
Title
Gene Therapy Product Disclosure
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-01-16 | House | REFERRED TO HEALTH & SOCIAL SERVICES |
2024-01-16 | House | HSS, L&C |
2024-01-16 | House | READ THE FIRST TIME - REFERRALS |
Subjects
Alaska State Sources
Type | Source |
---|---|
Summary | https://www.akleg.gov/basis/Bill/Detail/33?Root=HB216 |
Text | https://www.akleg.gov/PDF/33/Bills/HB0216A.PDF |